Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Journal Sections
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Collections
      • COVID-19 & Cancer Resource Center
      • Precision Medicine and Therapeutic Resistance
      • Clinical Trials
      • Immuno-oncology
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
    • Journal Press Releases
  • COVID-19
  • Webinars
  • 10th Anniversary
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Discovery
Cancer Discovery
  • Home
  • About
    • The Journal
    • AACR Journals
    • Journal Sections
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Collections
      • COVID-19 & Cancer Resource Center
      • Precision Medicine and Therapeutic Resistance
      • Clinical Trials
      • Immuno-oncology
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
    • Journal Press Releases
  • COVID-19
  • Webinars
  • 10th Anniversary
  • Search More

    Advanced Search

Table of Contents

In This Issue

  • In This Issue
    In This Issue
    Cancer Discov March 1 2021 11 (3) 521-523; DOI:10.1158/2159-8290.CD-ITI2021-0102

In the Spotlight

  • In the Spotlight
    Genetic Ancestry Correlations with Driver Mutations Suggest Complex Interactions between Somatic and Germline Variation in Cancer
    Felicia Gomez, Malachi Griffith and Obi L. Griffith
    Cancer Discov March 1 2021 11 (3) 534-536; DOI:10.1158/2159-8290.CD-21-0092

  • In the Spotlight
    At the Heart of Immune Checkpoint Inhibitor–Induced Immune Toxicity
    Arabella Young and Jeffrey A. Bluestone
    Cancer Discov March 1 2021 11 (3) 537-539; DOI:10.1158/2159-8290.CD-21-0091

  • In the Spotlight
    Poorer Clinical Outcomes for Black Patients with AML: A Wake-Up Call for Better Data and Greater Understanding of Cancer Outcomes in All Ethnic Groups
    Paresh Vyas
    Cancer Discov March 1 2021 11 (3) 540-541; DOI:10.1158/2159-8290.CD-20-1778

In Focus

  • In Focus
    Maturation Block in Childhood Cancer
    Sam Behjati, Richard J. Gilbertson and Stefan M. Pfister
    Cancer Discov March 1 2021 11 (3) 542-544; DOI:10.1158/2159-8290.CD-20-0926

Reviews

  • Reviews
    Opportunities and Challenges in Drug Development for Pediatric Cancers
    Theodore W. Laetsch, Steven G. DuBois, Julia Glade Bender, Margaret E. Macy and Lucas Moreno
    Cancer Discov March 1 2021 11 (3) 545-559; DOI:10.1158/2159-8290.CD-20-0779

  • Reviews | AuthorChoice
    Applications of CRISPR Genome Editing to Advance the Next Generation of Adoptive Cell Therapies for Cancer
    Samantha M. Fix, Amir A. Jazaeri and Patrick Hwu
    Cancer Discov March 1 2021 11 (3) 560-574; DOI:10.1158/2159-8290.CD-20-1083

  • Reviews
    Diffuse Glioma Heterogeneity and Its Therapeutic Implications
    James G. Nicholson and Howard A. Fine
    Cancer Discov March 1 2021 11 (3) 575-590; DOI:10.1158/2159-8290.CD-20-1474

Research Briefs

  • Research Briefs | AuthorChoice
    Genetic Ancestry Contributes to Somatic Mutations in Lung Cancers from Admixed Latin American Populations
    Jian Carrot-Zhang, Giovanny Soca-Chafre, Nick Patterson, Aaron R. Thorner, Anwesha Nag, Jacqueline Watson, Giulio Genovese, July Rodriguez, Maya K. Gelbard, Luis Corrales-Rodriguez, Yoichiro Mitsuishi, Gavin Ha, Joshua D. Campbell, Geoffrey R. Oxnard, Oscar Arrieta, Andres F. Cardona, Alexander Gusev and Matthew Meyerson
    Cancer Discov March 1 2021 11 (3) 591-598; DOI:10.1158/2159-8290.CD-20-1165

    Tumor sequencing data from patients with lung cancer from Latin America revealed that Native American ancestry significantly affected tumors' somatic mutation profiles; the observed disparities arose from germline differences rather than environmental exposures.

  • Research Briefs
    A Critical Role for Fas-Mediated Off-Target Tumor Killing in T-cell Immunotherapy
    Ranjan Upadhyay, Jonathan A. Boiarsky, Gvantsa Pantsulaia, Judit Svensson-Arvelund, Matthew J. Lin, Aleksandra Wroblewska, Sherry Bhalla, Nathalie Scholler, Adrian Bot, John M. Rossi, Norah Sadek, Samir Parekh, Alessandro Lagana, Alessia Baccarini, Miriam Merad, Brian D. Brown and Joshua D. Brody
    Cancer Discov March 1 2021 11 (3) 599-613; DOI:10.1158/2159-8290.CD-20-0756

    Apoptotic FAS–FASL signaling enabled CD8+ T cells to exert cytotoxic effects on antigen-negative “bystander” tumor cells in vivo, possibly explaining how antigen-specific chimeric antigen receptor T-cell therapies can eliminate tumors with heterogeneous antigen expression.

  • Research Briefs | AuthorChoice
    A Genetic Mouse Model Recapitulates Immune Checkpoint Inhibitor–Associated Myocarditis and Supports a Mechanism-Based Therapeutic Intervention
    Spencer C. Wei, Wouter C. Meijers, Margaret L. Axelrod, Nana-Ama A.S. Anang, Elles M. Screever, Elizabeth C. Wescott, Douglas B. Johnson, Elizabeth Whitley, Lorenz Lehmann, Pierre-Yves Courand, James J. Mancuso, Lauren E. Himmel, Benedicte Lebrun-Vignes, Matthew J. Wleklinski, Bjorn C. Knollmann, Jayashree Srinivasan, Yu Li, Oluwatomisin T. Atolagbe, Xiayu Rao, Yang Zhao, Jing Wang, Lauren I.R. Ehrlich, Padmanee Sharma, Joe-Elie Salem, Justin M. Balko, Javid J. Moslehi and James P. Allison
    Cancer Discov March 1 2021 11 (3) 614-625; DOI:10.1158/2159-8290.CD-20-0856

    A new mouse model of immune checkpoint inhibitor–induced myocarditis was developed, enabling the discovery that abatacept may be useful for ameliorating this condition; this finding was supported by results from a patient case series.

Research Articles

  • Research Articles | AuthorChoice
    Poor Survival and Differential Impact of Genetic Features of Black Patients with Acute Myeloid Leukemia
    Bhavana Bhatnagar, Jessica Kohlschmidt, Krzysztof Mrózek, Qiuhong Zhao, James L. Fisher, Deedra Nicolet, Christopher J. Walker, Alice S. Mims, Christopher Oakes, Brian Giacopelli, Shelley Orwick, Isaiah Boateng, James S. Blachly, Sophia E. Maharry, Andrew J. Carroll, Bayard L. Powell, Jonathan E. Kolitz, Richard M. Stone, John C. Byrd, Electra D. Paskett, Albert de la Chapelle, Ramiro Garzon and Ann-Kathrin Eisfeld
    Cancer Discov March 1 2021 11 (3) 626-637; DOI:10.1158/2159-8290.CD-20-1579

    Black patients with AML fared worse than white patients, a trend that held true after adjusting for socioeconomic status and molecular features, and the impact of common prognosticating mutations (e.g., those in NPM1) differed between the two groups.

  • Research Articles | AuthorChoice
    Aggressive PDACs Show Hypomethylation of Repetitive Elements and the Execution of an Intrinsic IFN Program Linked to a Ductal Cell of Origin
    Elisa Espinet, Zuguang Gu, Charles D. Imbusch, Nathalia A. Giese, Magdalena Büscher, Mariam Safavi, Silke Weisenburger, Corinna Klein, Vanessa Vogel, Mattia Falcone, Jacob Insua-Rodríguez, Manuel Reitberger, Vera Thiel, Steffi O. Kossi, Alexander Muckenhuber, Karnjit Sarai, Alex Y.L. Lee, Elyne Backx, Soheila Zarei, Matthias M. Gaida, Manuel Rodríguez-Paredes, Elisa Donato, Hsi-Yu Yen, Roland Eils, Matthias Schlesner, Nicole Pfarr, Thilo Hackert, Christoph Plass, Benedikt Brors, Katja Steiger, Dieter Weichenhan, H. Efsun Arda, Ilse Rooman, Janel L. Kopp, Oliver Strobel, Wilko Weichert, Martin R. Sprick and Andreas Trumpp
    Cancer Discov March 1 2021 11 (3) 638-659; DOI:10.1158/2159-8290.CD-20-1202

    Transcriptomic and DNA methylomic analyses revealed the existence of an aggressive, ductal cell–derived pancreatic ductal adenocarcinoma subgroup defined by low methylation of repetitive elements and expression of an IFN-linked transcriptional program.

  • Research Articles
    Cell of Origin Influences Pancreatic Cancer Subtype
    Brittany M. Flowers, Hang Xu, Abigail S. Mulligan, Kathryn J. Hanson, Jose A. Seoane, Hannes Vogel, Christina Curtis, Laura D. Wood and Laura D. Attardi
    Cancer Discov March 1 2021 11 (3) 660-677; DOI:10.1158/2159-8290.CD-20-0633

    Pancreatic ductal adenocarcinomas in adult genetically engineered mice could arise from either ductal or acinar cells, and tumors arising from each cell type had distinct transcriptional profiles that matched those of defined human pancreatic cancer subtypes.

  • Research Articles | AuthorChoice
    The Lipogenic Regulator SREBP2 Induces Transferrin in Circulating Melanoma Cells and Suppresses Ferroptosis
    Xin Hong, Whijae Roh, Ryan J. Sullivan, Keith H.K. Wong, Ben S. Wittner, Hongshan Guo, Taronish D. Dubash, Moshe Sade-Feldman, Benjamin Wesley, Elad Horwitz, Genevieve M. Boland, Dieuwke L. Marvin, Todd Bonesteel, Chenyue Lu, François Aguet, Risa Burr, Samuel S. Freeman, Laxmi Parida, Katherine Calhoun, Michelle K. Jewett, Linda T. Nieman, Nir Hacohen, Anders M. Näär, David T. Ting, Mehmet Toner, Shannon L. Stott, Gad Getz, Shyamala Maheswaran and Daniel A. Haber
    Cancer Discov March 1 2021 11 (3) 678-695; DOI:10.1158/2159-8290.CD-19-1500

    Melanoma circulating tumor cells (CTC) prevented ferroptotic death by upregulating SREBF2-mediated lipogenic pathways and iron homeostatic pathways, and blocking this escape mechanism by knocking out the gene encoding transferrin hindered CTC tumor formation.

  • Research Articles | AuthorChoice
    An Empirical Antigen Selection Method Identifies Neoantigens That Either Elicit Broad Antitumor T-cell Responses or Drive Tumor Growth
    Hubert Lam, Lisa K. McNeil, Hanna Starobinets, Victoria L. DeVault, Roger B. Cohen, Przemyslaw Twardowski, Melissa L. Johnson, Maura L. Gillison, Mark N. Stein, Ulka N. Vaishampayan, Arthur P. DeCillis, James J. Foti, Vijetha Vemulapalli, Emily Tjon, Kyle Ferber, Daniel B. DeOliveira, Wendy Broom, Parul Agnihotri, Elizabeth M. Jaffee, Kwok-Kin Wong, Charles G. Drake, Pamela M. Carroll, Thomas A. Davis and Jessica Baker Flechtner
    Cancer Discov March 1 2021 11 (3) 696-713; DOI:10.1158/2159-8290.CD-20-0377

    An ex vivo bioassay, ATLAS, was able to identify stimulatory and inhibitory neoantigens for the design of personalized anticancer vaccines; this assay pinpointed anti- and protumorigenic antigens, as demonstrated via in vivo experiments.

  • Research Articles | AuthorChoice
    Durable Suppression of Acquired MEK Inhibitor Resistance in Cancer by Sequestering MEK from ERK and Promoting Antitumor T-cell Immunity
    Aayoung Hong, Marco Piva, Sixue Liu, Willy Hugo, Shirley H. Lomeli, Vincent Zoete, Christopher E. Randolph, Zhentao Yang, Yan Wang, Jordan J. Lee, Skylar J. Lo, Lu Sun, Agustin Vega-Crespo, Alejandro J. Garcia, David B. Shackelford, Steven M. Dubinett, Philip O. Scumpia, Stephanie D. Byrum, Alan J. Tackett, Timothy R. Donahue, Olivier Michielin, Sheri L. Holmen, Antoni Ribas, Gatien Moriceau and Roger S. Lo
    Cancer Discov March 1 2021 11 (3) 714-735; DOI:10.1158/2159-8290.CD-20-0873

    Type II RAF inhibitors provided distinct advantages over Type I RAF inhibitors when used in combination with MEK inhibitors in models with MAPK pathway alterations.

  • Research Articles | AuthorChoice
    Epigenetic and Transcriptional Control of the Epidermal Growth Factor Receptor Regulates the Tumor Immune Microenvironment in Pancreatic Cancer
    Jinyang Li, Salina Yuan, Robert J. Norgard, Fangxue Yan, Yu H. Sun, Il-Kyu Kim, Allyson J. Merrell, Yogev Sela, Yanqing Jiang, Natarajan V. Bhanu, Benjamin A. Garcia, Robert H. Vonderheide, Andrés Blanco and Ben Z. Stanger
    Cancer Discov March 1 2021 11 (3) 736-753; DOI:10.1158/2159-8290.CD-20-0519

    A screen for tumor cell–intrinsic suppressors of antitumor immunity identified the histone methyltransferase KDM3A, which activated the expression of EGFR to keep the tumor immune microenvironment in a non–T-cell-inflamed state.

  • Research Articles | AuthorChoice
    Phenotypic Mapping of Pathologic Cross-Talk between Glioblastoma and Innate Immune Cells by Synthetic Genetic Tracing
    Matthias Jürgen Schmitt, Carlos Company, Yuliia Dramaretska, Iros Barozzi, Andreas Göhrig, Sonia Kertalli, Melanie Großmann, Heike Naumann, Maria Pilar Sanchez-Bailon, Danielle Hulsman, Rainer Glass, Massimo Squatrito, Michela Serresi and Gaetano Gargiulo
    Cancer Discov March 1 2021 11 (3) 754-777; DOI:10.1158/2159-8290.CD-20-0219

    A genetic tracing method using synthetic reporters comprised of glioblastoma subtypespecific cis-regulatory elements allowed mapping of cell states and fate transitions.

  • Research Articles | AuthorChoice
    Machine-Learning and Chemicogenomics Approach Defines and Predicts Cross-Talk of Hippo and MAPK Pathways
    Trang H. Pham, Thijs J. Hagenbeek, Ho-June Lee, Jason Li, Christopher M. Rose, Eva Lin, Mamie Yu, Scott E. Martin, Robert Piskol, Jennifer A. Lacap, Deepak Sampath, Victoria C. Pham, Zora Modrusan, Jennie R. Lill, Christiaan Klijn, Shiva Malek, Matthew T. Chang and Anwesha Dey
    Cancer Discov March 1 2021 11 (3) 778-793; DOI:10.1158/2159-8290.CD-20-0706

    A lineage-independent, unbiased approach to characterize Hippo pathway activity and dependency identified cross-talk between the Hippo and MAPK pathways and suggested a potential therapeutic strategy for Hippodependent cancers.

News in Brief

  • News in Brief
    People
    Cancer Discov March 1 2021 11 (3) 524-524; DOI:10.1158/2159-8290.CD-NB2021-0308

  • News in Brief
    Congress Approves Increase in Cancer Funding
    Cancer Discov March 1 2021 11 (3) 524-524; DOI:10.1158/2159-8290.CD-NB2021-0302

  • News in Brief
    Devil Facial Tumor Disease Turns Endemic
    Cancer Discov March 1 2021 11 (3) 524-525; DOI:10.1158/2159-8290.CD-NB2021-0301

  • News in Brief
    Study Offers Insights into Gastric Cancer
    Cancer Discov March 1 2021 11 (3) 525-526; DOI:10.1158/2159-8290.CD-NB2021-0305

  • News in Brief
    The National Cancer Act at 50
    Cancer Discov March 1 2021 11 (3) 526-526; DOI:10.1158/2159-8290.CD-NB2021-0310

  • News in Brief
    Noted
    Cancer Discov March 1 2021 11 (3) 526-526; DOI:10.1158/2159-8290.CD-NB2021-0307

  • News in Brief
    Agios Exits Oncology
    Cancer Discov March 1 2021 11 (3) OF1-OF1; DOI:10.1158/2159-8290.CD-NB2021-0303

  • News in Brief
    Liver Metastases Impede Checkpoint Inhibitors
    Cancer Discov March 1 2021 11 (3) OF2-OF2; DOI:10.1158/2159-8290.CD-NB2021-0304

  • News in Brief
    Study Documents Vaginal Transmission of Cancer
    Cancer Discov March 1 2021 11 (3) OF3-OF3; DOI:10.1158/2159-8290.CD-NB2021-0306

News in Depth

  • News in Depth | Free Article
    What Biden's Presidency Will Mean for Cancer
    Cancer Discov March 1 2021 11 (3) 527-528; DOI:10.1158/2159-8290.CD-ND2021-0101

Research Watch

  • Epigenetics

    • Research Watch
      FBXO44 Silences Repetitive Elements during DNA Replication in Cancer
      Cancer Discov March 1 2021 11 (3) 531-531; DOI:10.1158/2159-8290.CD-RW2021-003

    • Research Watch
      Computational Tool Characterizes Previously Unidentified Tumor Subtypes
      Cancer Discov March 1 2021 11 (3) 530-530; DOI:10.1158/2159-8290.CD-RW2021-007

  • Structural Biology

    • Research Watch
      Cryo-EM Structures Reveal Mechanism of Anticancer MCT1 Inhibitors
      Cancer Discov March 1 2021 11 (3) 529-529; DOI:10.1158/2159-8290.CD-RW2021-004

    • Research Watch
      Structures Identify Selpercatinib and Pralsetinib Resistance Mechanisms
      Cancer Discov March 1 2021 11 (3) OF8-OF8; DOI:10.1158/2159-8290.CD-RW2021-009

  • Splicing

    • Research Watch
      RNA Missplicing Triggers Antiviral Immune Response in Breast Cancer
      Cancer Discov March 1 2021 11 (3) 529-529; DOI:10.1158/2159-8290.CD-RW2021-008

  • Breast Cancer

    • Research Watch
      Androgen Receptor Functions as a Tumor Suppressor in ER+ Breast Cancer
      Cancer Discov March 1 2021 11 (3) 530-530; DOI:10.1158/2159-8290.CD-RW2021-012

  • Vaccines

    • Research Watch
      Immune Responses to Personalized Neoantigen Vaccines Are Durable
      Cancer Discov March 1 2021 11 (3) 531-531; DOI:10.1158/2159-8290.CD-RW2021-013

  • Techniques

    • Research Watch
      Computational Method Enhances Analysis of Single-Cell Transcriptomics
      Cancer Discov March 1 2021 11 (3) 533-533; DOI:10.1158/2159-8290.CD-RW2021-014

  • Immunotherapy

    • Research Watch
      Oncolytic Virotherapy Shows Promise for Cutaneous B-cell Lymphoma
      Cancer Discov March 1 2021 11 (3) OF10-OF10; DOI:10.1158/2159-8290.CD-RW2021-011

    • Research Watch
      A Pan-Cancer Meta-Analysis of Immune Checkpoint Inhibitor Response
      Cancer Discov March 1 2021 11 (3) 532-532; DOI:10.1158/2159-8290.CD-RW2021-016

  • Genetics

    • Research Watch
      Chromothripsis Generates Oncogene-Containing Extrachromosomal DNA
      Cancer Discov March 1 2021 11 (3) OF5-OF5; DOI:10.1158/2159-8290.CD-RW2021-002

    • Research Watch
      The Spindle Assembly Checkpoint Is a Vulnerability of Aneuploid Cells
      Cancer Discov March 1 2021 11 (3) 533-533; DOI:10.1158/2159-8290.CD-RW2021-017

    • Research Watch
      Noncanonical Open Reading Frames Produce Functional Proteins in Cancer
      Cancer Discov March 1 2021 11 (3) 532-532; DOI:10.1158/2159-8290.CD-RW2021-018

  • Clinical Trials

    • Research Watch
      First Trial of a DARPin for Cancer Shows Promising Efficacy Signal
      Cancer Discov March 1 2021 11 (3) OF4-OF4; DOI:10.1158/2159-8290.CD-RW2021-001

    • Research Watch
      A CD40 Agonistic Antibody Shows Signs of Efficacy in Pancreatic Cancer
      Cancer Discov March 1 2021 11 (3) OF7-OF7; DOI:10.1158/2159-8290.CD-RW2021-006

  • Immunology

    • Research Watch
      Epstein–Barr Virus–Induced Antitumor Immune Response May Be Harnessable
      Cancer Discov March 1 2021 11 (3) OF6-OF6; DOI:10.1158/2159-8290.CD-RW2021-005

  • Artificial Intelligence

    • Research Watch
      Deep Learning Algorithm Aids Breast Cancer Detection by Mammography
      Cancer Discov March 1 2021 11 (3) OF9-OF9; DOI:10.1158/2159-8290.CD-RW2021-010

  • Brain Cancer

    • Research Watch
      Medulloblastoma Relapse Data Reveal Subgroup-Dependent Variations in Outcome
      Cancer Discov March 1 2021 11 (3) OF11-OF11; DOI:10.1158/2159-8290.CD-RW2021-015

Back to top
PreviousNext
Cancer Discovery: 11 (3)
March 2021
Volume 11, Issue 3
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Editorial Board (PDF)

Sign up for alerts

Jump to

  • In This Issue
  • In the Spotlight
  • In Focus
  • Reviews
  • Research Briefs
  • Research Articles
  • News in Brief
  • News in Depth
  • Research Watch
    • Epigenetics
    • Structural Biology
    • Splicing
    • Breast Cancer
    • Vaccines
    • Techniques
    • Immunotherapy
    • Genetics
    • Clinical Trials
    • Immunology
    • Artificial Intelligence
    • Brain Cancer
Advertisement
  • Most Cited
  • Most Read
Loading
  • The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
  • Macrophages Regulate Response to Chemotherapy
  • Core Resistance Mechanisms and Genetic Evolution of Melanoma under BRAF Inhibitor Selection
  • Novel Mutant-Selective EGFR Inhibitor Overcomes Drug Resistance
  • EGFR Mediates RAF Inhibitor Resistance in BRAF-Mutant Colorectal Cancer
More...
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • OnlineFirst
  • Current Issue
  • Past Issues

Info For

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Discovery

  • About the Journal
  • Editors
  • Journal Sections
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Discovery
eISSN: 2159-8290
ISSN: 2159-8274

Advertisement